Ticker
AQSTCompany Name
AQUESTIVE THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -50.02M | -113.34% | $ 44.13M |
3/31/2025 | $ -49.04M | -90.43% | $ 54.23M |
12/31/2024 | $ -35.92M | -62.4% | $ 57.56M |
9/30/2024 | $ -34.37M | -58.36% | $ 58.9M |
6/30/2024 | $ -24.91M | -42.68% | $ 58.36M |
3/31/2024 | $ -26.6M | -51.65% | $ 51.5M |
12/31/2023 | $ -7.38M | -14.58% | $ 50.58M |
9/30/2023 | $ 6M | 12.49% | $ 48.06M |
6/30/2023 | $ 11.09M | 23.85% | $ 46.52M |
3/31/2023 | $ 12.59M | 27.04% | $ 46.54M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for AQUESTIVE THERAPEUTICS INC is calculated as follows: FCF [ $ -42.89M ] / Revenues [ $ 55.12M ]
(=) FCF % [ -77.81% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |